Multi-Peptide Blends · Research deep dive
GLOW Blend (GHK-Cu / BPC-157 / TB-500): the cited literature
Every study referenced in the GLOW Blend (GHK-Cu / BPC-157 / TB-500) monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, GLOW Blend (GHK-Cu / BPC-157 / TB-500) is studied at 1 mg – 3 mg per administration, typically once daily (combined peptide mass). The reference walkthrough below maps each citation to what it actually showed.
References covered
GHK peptide as a natural modulator of multiple cellular pathways
BioMed Res. Int., 2015
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for GLOW Blend (GHK-Cu / BPC-157 / TB-500).